USPTO AI-powered patent search, Artificial intelligence in patents, AI in patent examination.

USPTO Launches AI-Powered Patent Search Pilot to Streamline Examination

The USPTO is once again making headlines — but this time, its initiative goes beyond routine innovation. It’s a future-shaping move that could redefine how patents are examined. USPTO AI-powered patent search is preparing to launch a pilot program for its new AI-powered Automated Search system, designed to test how artificial intelligence can help find […]

Utility Model vs Patent, Utility Model Intellectual Property Rights, Utility Model Filing Process

What Are Utility Models and How Do They Differ From Patents?

Innovation is the foundation of every successful business. In today’s competitive world, companies are constantly searching for better opportunities to create and protect new ideas — what we often call inventions. Utility Model vs Patent Typically, these innovations are protected through a patent. However, not every business needs or can afford the long and costly […]

Natsoft vs Hexaware Patent case, Hexaware patent infringement

US Tech Firm Natsoft Drags Hexaware Into $500M Patent Fight

Hexaware Technologies, a leading Indian IT services company, is facing a massive $500 million lawsuit filed by US-based Natsoft Corporation and its subsidiary Updraft. Natsoft vs Hexaware patent case The case revolves around alleged contract violations and patent infringement, making it one of the biggest intellectual property rights (IPR) disputes in the IT sector. This […]

mRNA TALEN patent infringement case, mRNA technology patent case, Cellectis AstraZeneca patent dispute.

AstraZeneca Faces and Cellectis Inc. Patent Infringement Lawsuit by Factor Bioscience Over mRNA Gene-Editing Tech

A major patent dispute is making headlines in the pharmaceutical world, involving three big names in biotech and drug development.  mRNA TALEN patent infringement case Factor Bioscience Inc., a U.S.-based biotech company, has filed a patent infringement lawsuit against AstraZeneca PLC (a UK-based pharmaceutical giant) and Cellectis Inc. (a French-American biopharmaceutical firm). Factor Bioscience accuses […]

NIT Rourkela Patents AI Model

NIT Rourkela Secures Patent for AI Model on Road Safety Using VANET

A major development has arrived in the field of Indian intellectual property, one that could transform the country’s approach to road safety and traffic technology. NIT Rourkela Patents AI Model for Road Safety. The research team at NIT Rourkela (NIT-R) has successfully secured a patent under Indian patent filing law for an AI-based model designed […]

AYUSH innovation patent guidelines, AYUSH patent guidelines India, AYUSH patent application process

AYUSH Patent Guidelines: Protecting India’s Traditional Knowledge Through Innovation

India is known across the world for its rich food, diverse culture, vibrant festivals, and deep-rooted religions. AYUSH innovation patent guidelines. But beyond these, one of the most remarkable aspects of India is its vast traditional knowledge and heritage of innovations. Intellectual property rights (IPR). From ancient medical practices to unique cultural wisdom, this legacy […]

Novartis Vymada Patent Revoked, Entresto patent cancelled India,

India Cancels Novartis Vymada Patent, Opens Market to Generics

A major update has been released by the Indian Patent Office (IPO) that could significantly reshape the Indian pharmaceutical market. Novartis Vymada Patent Revoked in India. The IPO has revoked/canceled the patent held by Novartis, the Swiss multinational pharmaceutical giant based in Basel, Switzerland, on its blockbuster cardiac drug Vymada (also known globally as Entresto). […]